News Articles for William Dolphin

Shares in Avita Medical have hit a 2014 low following the company's announcement efforts to commercialise in the UK have hit a snag.

Perth biotechnology firm Avita Medical has announced major changes to a clinical trial in the US it hopes will improve shareholder confidence.

WA biotechs are drowning in a sea of red as yet more negative results are reported.

Biotech company Avita Medical has appointed a new chairman after shareholder outrage against the company's remuneration report last year claimed the scalp of former chairman Dalton Gooding.

William Dolphin has agreed to step down as chief executive of biotech company Avita Medical, and Dalton Gooding has resigned after announcing his intention to do so at the company's annual general meeting in November.

FEATURE: It has been a difficult year for many of WA's listed entities, but investors are backing the performance of most of the state's top executives.

Dalton Gooding has agreed to stand down as chairman of biotech company Avita Medical but shareholders today supported the re-elect

Nedlands-based Visiomed Group Ltd has secured United States FDA clearance for its redesigned and improved 'Funhaler' paediatric asthma incentive spacer.